Advice
In the absence of a submission from the holder of the marketing authorisation.
nepafenac (Nevanac®) is not recommended for use within NHS Scotland for prevention and treatment of postoperative pain and inflammation associated with cataract surgery.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHS Scotland
Download detailed advice48KB (PDF)
Medicine details
- Medicine name:
- nepafenac (Nevanac)
- SMC ID:
- 588/09
- Indication:
- Prevention and treatment of postoperative pain and inflammation associated with cataract surgery
- Pharmaceutical company
- Alcon Laboratories UK Ltd
- BNF chapter
- Eye
- Submission type
- Non submission
- Status
- Not recommended
- Date advice published
- 09 November 2009